跳至主要内容
临床试验/NL-OMON51321
NL-OMON51321招募中不适用

Percutaneous intratumoural holmium microspheres brachytherapy for patients with pancreatic cancer; a single centre, prospective safety and feasibility study - SLOTH-2a

Radboud Universitair Medisch Centrum0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Female or male aged 18 years and over.
  • 2. Pathologically proven pancreatic adenocarcinoma, also known as pancreatic
  • ductal adenocarcinoma.
  • 3. Patient is deemed ineligible for surgical resection of the pancreatic cancer:
  • a. in accordance with consensus at the multidisciplinary meetings/discussions,
  • b. and/or the patient refuses to undergo surgical resection out of personal
  • 4. Life expectancy of 16 weeks or longer.
  • 5. World Health Organisation (WHO) Performance status 0-1
  • 6. One or more measurable pancreatic tumours of at least 20 mm in the longest
  • diameter by spiral CT or MRI according to the Response Evaluation Criteria in
  • Solid Tumours (RECIST) 1.1 criteria.
  • 7. Negative pregnancy test for women of childbearing potential.

排除标准

  • 1. Radiation therapy within the last 4 weeks before the start of study therapy.
  • 2. Chemotherapy within the last 2 weeks before the start of study therapy.
  • 3. Calcifications in the pancreas or tumour that are highly expected to
  • obstruct the needle tract
  • 4. Any unresolved toxicity >= grade 3 from the National Cancer Institute (NCI),
  • Common Terminology Criteria for Adverse Events (CTCAE version 5.0) from
  • previous anti-cancer therapy.
  • 5. Leukocytes < 3.0 109/l and/or platelet count < 75 109/l.
  • 6. Kidney failure: Creatine > 165 µmol/l and/or eGFR < 60 ml/min/1,73m2
  • 7. Significant cardiac event classification of heart disease >=2 within 3 months
  • before entry, or presence of cardiac disease that in the opinion of the
  • Investigator increases the risk of ventricular arrhythmia.
  • 8. Patient is deemed ineligible for implantation of 166Ho by an expert panel
  • (surgeon, nuclear medicine physician, interventional radiologist, radiologist,
  • and researcher) due to tumour anatomy, nearby structures, patient status or a
  • combination.
  • 9. Pregnancy or breast feeding (women of child-bearing potential).
  • 10. Patients suffering from psychic disorders that make a comprehensive
  • judgement impossible, such as psychosis, hallucinations and/or depression.
  • 11. Patients who are declared incompetent.

研究者

相似试验